Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Carcinoma, Hepatocellular 22Stomach Neoplasms 20Carcinoma, Non-Small-Cell Lung 16Colorectal Neoplasms 9Nasopharyngeal Carcinoma 5Lung Neoplasms 5Esophageal Squamous Cell Carcinoma 5Small Cell Lung Carcinoma 4Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Lymphoma, Extranodal NK-T-Cell 3Liver Neoplasms 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Carcinoma 3Nonsquamous Non-Small Cell Lung Cancer 2Nasopharyngeal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Neuroendocrine 2Advanced Biliary Tract Cancer 2Unresectable Locally Advanced Pancreatic Cancer 1Triple Negative Breast Neoplasms 1Tislelizumab 1Thoracic Neoplasms 1Thoracic Malignancies 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Respiratory Tract Diseases 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1

Interventions

Cisplatin 44Paclitaxel 21Radiotherapy 20Brachytherapy 19Carboplatin 18Bevacizumab 7Drug Therapy 6camrelizumab 5toripalimab 4nimotuzumab 4Radiation 4Neoadjuvant Therapy 4Gemcitabine 4tislelizumab 3sintilimab 3pembrolizumab 3apatinib 3Vaccines 3TP protocol 3Surgical Procedures, Operative 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3nedaplatin 2fludarabine 2endostar protein 2anlotinib 2Topotecan 2Surveys and Questionnaires 2Sentinel Lymph Node Biopsy 2Radiotherapy, Intensity-Modulated 2Mindfulness 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Uterine Cervical Neoplasms × sintilimab × Clear all
NCT05105672 2021-12-28

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

The Affiliated Hospital of Xuzhou Medical University

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04918628 2021-06-09

CRTCP

Taizhou Hospital

Phase 2 Unknown
50 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04096911 2019-09-20

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Northern Jiangsu People's Hospital

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡